Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/07/2024 BST 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI
104193cfe1104.LAF88YuT-u93k00q-64l_wNaKjLRz2XsBmnWxEkrBAA.TTIjk8n_u4wOwwcHmuFkqE0eEle8rR3faR-giwJjWzBpNgSm2t-bnx3GOg~b490eff8425c0a4a89b54060c81b3b02
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Charts Context Therapeutics Inc.
  6. News Chart